TRAINING PROGRAM IN ACADEMIC MEDICAL ONCOLOGY/HEMATOLOGY

这一竞争性继续培训计划申请的目的是扩大圣安东尼奥德克萨斯大学健康科学中心在学术医学肿瘤学和血液学方面发展和培训新医生/科学家的机会。这个综合的3到4年的项目主要针对博士后医学博士候选人（博士后博士或药学博士）候选人，偶尔会选择)，在17名优秀和经验丰富的教师调查员之一的指导下，开始一个密集的临床年，以获得董事会资格和/或转化研究所需的经验。研究培训是围绕美国国立卫生研究院指定的综合癌症中心（SACI圣安东尼奥癌症研究所）赞助的5个研究项目进行的，包括：乳腺癌，生长因子，药物开发，分子遗传学，癌症预防和健康促进。教师导师，代表7个不同的部门，属于一个或多个这些多部门的研究项目。研究培训由独特的正式课程补充，包括医学写作和拨款准备、生物统计学方法学、临床肿瘤学、生物学、分子生物学和伦理学，以及一系列会议、研究研讨会、数据审查会议和研究计划会议。医学肿瘤学培训生是从完成3年住院医师项目的申请人中挑选出来的。选择参加该研究培训计划的学员（2个4年级和2个5年级）必须承诺作为学术医学的医生/科学家的职业生涯，并且必须有作为学术研究者的成就记录。具有医学博士学位或有实验室研究经验者优先考虑。招聘少数族裔学员也是我们过去成功的少数族裔招聘计划的一个目标。学员将在以下几个领域进行深入培训：乳腺癌和细胞生物学、癌基因和抑制基因、基因表达调控、耐药、生长因子和信号转导途径、恶性肿瘤骨细胞代谢、分子遗传学和造血干细胞分化。研究培训至少2年。这些项目包括与来自其他癌症中心研究项目和其他UTHSCSA部门的教师合作，包括临床和基础科学，以确保最佳的培训体验。完成本课程的学员将获得临床、研究、教学和管理技能，为他们作为医生/科学家从事有竞争力的研究工作奠定坚实的基础。

The purpose of this competing continuation Train Program Application is to extend the opportunity that exists at the University of Texas Health Science Center at San Antonio for the development and training of new physician/scientists in academic Medical Oncology and Hematology. This integrated 3 to 4-year program primarily for postdoctoral M.D. candidates (postdoc Ph.D. or Pharm.D.) candidates occasionally selected) begins with an intensive clinical year to obtain the experience necessary for board eligibility and/or translational research under the preceptorship of one of 17 outstanding and experienced faculty investigators. Research training is structured around 5 of the research programs sponsored by our NIH-designated Comprehensive Cancer Center (San Antonio Cancer Institute of SACI) including: Breast Cancer, Growth Factors, Drug Development, Molecular Genetics, and Cancer Prevention and Health Promotion. The faculty preceptors, representing 7 different departments, belong to one or more of these multi-departmental research programs. Research training is supplemented by unique formal coursework in medical writing and grant preparation, biostatistics methodology, clinical oncology, biology, molecular biology and ethics, and by a series of conferences, research seminars, data review sessions and research programs meetings. Medical Oncology trainees are selected from applicants who have completed a 3-year medical residency program. Trainees (2 Year 4 and 2 Year 5) selected for this Research Training Program must have a commitment to a career as a physician/scientist in academic medicine and must have a record of achievement indication promise as an academic investigator. Candidates with M.D. and Ph.D. degrees or those with prior laboratory research experience are given preference. Recruitment of minority trainees is also a goal to be accomplished through our Minority Recruitment Program that has been successful in the past. Trainees will engage in in depth training in one of several areas including and cellular biology of breast cancer, oncogenes and suppressor genes, regulation of gene expression, drug resistance, growth factors and signal transduction pathways, bone cell metabolism in malignancy, molecular genetics and hematopoietic stem cell differentiation. Research training is for a minimum of 2 years. These projects involve collaborations with faculty from other Cancer Center Research Programs and other UTHSCSA Departments, both clinical and basic science, to ensure an optimal training experience. Trainees completing this program will have acquired the clinical, research, teaching, and administrative skills that will provide them with a strong foundation for competitive research careers as physician/scientists.